ID   YLAT2_HUMAN             Reviewed;         515 AA.
AC   Q92536; Q68DS4; Q7L1N3;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   10-JUN-2008, sequence version 3.
DT   15-MAR-2017, entry version 136.
DE   RecName: Full=Y+L amino acid transporter 2;
DE   AltName: Full=Cationic amino acid transporter, y+ system;
DE   AltName: Full=Solute carrier family 7 member 6;
DE   AltName: Full=y(+)L-type amino acid transporter 2;
DE            Short=Y+LAT2;
DE            Short=y+LAT-2;
GN   Name=SLC7A6 {ECO:0000312|HGNC:HGNC:11064};
GN   Synonyms=KIAA0245 {ECO:0000312|EMBL:BAA13376.2};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   TISSUE=Myoblast {ECO:0000269|PubMed:9829974};
RX   PubMed=9829974; DOI=10.1074/jbc.273.49.32437;
RA   Torrents D., Estevez R., Pineda M., Fernandez E., Lloberas J.,
RA   Shi Y.-B., Zorzano A., Palacin M.;
RT   "Identification and characterization of a membrane protein (y+L amino
RT   acid transporter-1) that associates with 4F2hc to encode the amino
RT   acid transport activity y+L. A candidate gene for lysinuric protein
RT   intolerance.";
RL   J. Biol. Chem. 273:32437-32445(1998).
RN   [2] {ECO:0000312|EMBL:BAA13376.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone marrow {ECO:0000312|EMBL:BAA13376.2};
RX   PubMed=9039502; DOI=10.1093/dnares/3.5.321;
RA   Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O.,
RA   Tanaka A., Kotani H., Miyajima N., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. VI.
RT   The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by
RT   analysis of cDNA clones from cell line KG-1 and brain.";
RL   DNA Res. 3:321-329(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Salivary gland;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4] {ECO:0000312|EMBL:CAH18146.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000312|EMBL:AAH28216.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Leukocyte {ECO:0000312|EMBL:AAH28216.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=11078698;
RA   Dall'Asta V., Bussolati O., Sala R., Rotoli B.M., Sebastio G.,
RA   Sperandeo M.P., Andria G., Gazzola G.C.;
RT   "Arginine transport through system y(+)L in cultured human
RT   fibroblasts: normal phenotype of cells from LPI subjects.";
RL   Am. J. Physiol. 279:C1829-C1837(2000).
RN   [7] {ECO:0000305}
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND INHIBITION.
RX   PubMed=10903140; DOI=10.1042/bj3490787;
RA   Broeer A., Wagner C.A., Lang F., Broeer S.;
RT   "The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates
RT   arginine efflux in exchange with glutamine.";
RL   Biochem. J. 349:787-795(2000).
RN   [8] {ECO:0000305}
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=11311135;
RA   Broeer A., Friedrich B., Wagner C.A., Fillon S., Ganapathy V.,
RA   Lang F., Broeer S.;
RT   "Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires
RT   different domains.";
RL   Biochem. J. 355:725-731(2001).
RN   [9] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=11742806;
RA   Sala R., Rotoli B.M., Colla E., Visigalli R., Parolari A.,
RA   Bussolati O., Gazzola G.C., Dall'Asta V.;
RT   "Two-way arginine transport in human endothelial cells: TNF-alpha
RT   stimulation is restricted to system y(+).";
RL   Am. J. Physiol. 282:C134-C143(2002).
RN   [10] {ECO:0000305}
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=14603368; DOI=10.1113/eph8802647;
RA   Arancibia-Garavilla Y., Toledo F., Casanello P., Sobrevia L.;
RT   "Nitric oxide synthesis requires activity of the cationic and neutral
RT   amino acid transport system y+L in human umbilical vein endothelium.";
RL   Exp. Physiol. 88:699-710(2003).
RN   [11] {ECO:0000305}
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15280038; DOI=10.1016/j.febslet.2004.06.086;
RA   Rotoli B.M., Bussolati O., Sala R., Barilli A., Talarico E.,
RA   Gazzola G.C., Dall'Asta V.;
RT   "INFgamma stimulates arginine transport through system y+L in human
RT   monocytes.";
RL   FEBS Lett. 571:177-181(2004).
RN   [12] {ECO:0000305}
RP   SUBCELLULAR LOCATION.
RX   PubMed=15756301; DOI=10.1038/sj.ejhg.5201376;
RA   Sperandeo M.P., Paladino S., Maiuri L., Maroupulos G.D., Zurzolo C.,
RA   Taglialatela M., Andria G., Sebastio G.;
RT   "A y(+)LAT-1 mutant protein interferes with y(+)LAT-2 activity:
RT   implications for the molecular pathogenesis of lysinuric protein
RT   intolerance.";
RL   Eur. J. Hum. Genet. 13:628-634(2005).
RN   [13] {ECO:0000305}
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND INHIBITION.
RX   PubMed=16785209; DOI=10.1080/09687860600652968;
RA   Chubb S., Kingsland A.L., Broeer A., Broeer S.;
RT   "Mutation of the 4F2 heavy-chain carboxy terminus causes y+ LAT2
RT   light-chain dysfunction.";
RL   Mol. Membr. Biol. 23:255-267(2006).
RN   [14] {ECO:0000305}
RP   FUNCTION, TISSUE SPECIFICITY, AND INHIBITION.
RX   PubMed=17329401; DOI=10.1152/ajpcell.00323.2006;
RA   Rotmann A., Simon A., Martine U., Habermeier A., Closs E.I.;
RT   "Activation of classical protein kinase C decreases transport via
RT   systems y+ and y+L.";
RL   Am. J. Physiol. 292:C2259-C2268(2007).
RN   [15] {ECO:0000305}
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=17197568; DOI=10.1167/iovs.06-0398;
RA   Kaneko S., Ando A., Okuda-Ashitaka E., Maeda M., Furuta K., Suzuki M.,
RA   Matsumura M., Ito S.;
RT   "Ornithine transport via cationic amino acid transporter-1 is involved
RT   in ornithine cytotoxicity in retinal pigment epithelial cells.";
RL   Invest. Ophthalmol. Vis. Sci. 48:464-471(2007).
CC   -!- FUNCTION: Involved in the sodium-independent uptake of dibasic
CC       amino acids and sodium-dependent uptake of some neutral amino
CC       acids. Requires coexpression with SLC3A2/4F2hc to mediate the
CC       uptake of arginine, leucine and glutamine. Also acts as an
CC       arginine/glutamine exchanger, following an antiport mechanism for
CC       amino acid transport, influencing arginine release in exchange for
CC       extracellular amino acids. Plays a role in nitric oxide synthesis
CC       in human umbilical vein endothelial cells (HUVECs) via transport
CC       of L-arginine. Involved in the transport of L-arginine in
CC       monocytes. Reduces uptake of ornithine in retinal pigment
CC       epithelial (RPE) cells. {ECO:0000269|PubMed:10903140,
CC       ECO:0000269|PubMed:11311135, ECO:0000269|PubMed:14603368,
CC       ECO:0000269|PubMed:15280038, ECO:0000269|PubMed:16785209,
CC       ECO:0000269|PubMed:17197568, ECO:0000269|PubMed:17329401,
CC       ECO:0000269|PubMed:9829974}.
CC   -!- ENZYME REGULATION: Arginine transport is strongly inhibited by
CC       lysine, glutamate, leucine, glutamine, methionine and histidine,
CC       in the presence of Na(+). Also inhibited by protein kinase C (PKC)
CC       and treatment with phorbol-12-myristate-13-acetate (PMA). Mutual
CC       inhibition is observed when leucine or glutamine is used as
CC       substrate. Inhibition of arginine and leucine uptake also occurs
CC       when SLC3A2/4F2hc is either truncated at its C-terminus or mutated
CC       at critical residues within the terminal 15 amino acids.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=295 uM for glutamine (in the presence of NaCl)
CC         {ECO:0000269|PubMed:10903140};
CC         KM=236 uM for leucine (in the presence of NaCl)
CC         {ECO:0000269|PubMed:10903140};
CC         KM=120 uM for arginine (in the presence of NaCl)
CC         {ECO:0000269|PubMed:10903140};
CC         KM=138 uM for arginine (in the absence of NaCl)
CC         {ECO:0000269|PubMed:10903140};
CC   -!- SUBUNIT: Disulfide-linked heterodimer with the amino acid
CC       transport protein SLC3A2/4F2hc. {ECO:0000269|PubMed:11311135,
CC       ECO:0000269|PubMed:16785209}.
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane
CC       {ECO:0000269|PubMed:15756301, ECO:0000269|PubMed:16785209}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:15756301,
CC       ECO:0000269|PubMed:16785209}.
CC   -!- TISSUE SPECIFICITY: Expressed in normal fibroblasts and those from
CC       LPI patients. Also expressed in HUVECs, monocytes, RPE cells, and
CC       various carcinoma cell lines. {ECO:0000269|PubMed:11078698,
CC       ECO:0000269|PubMed:11742806, ECO:0000269|PubMed:14603368,
CC       ECO:0000269|PubMed:15280038, ECO:0000269|PubMed:17197568,
CC       ECO:0000269|PubMed:17329401}.
CC   -!- SIMILARITY: Belongs to the amino acid-polyamine-organocation (APC)
CC       superfamily. L-type amino acid transporter (LAT) (TC 2.A.3.8)
CC       family. {ECO:0000255}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA13376.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D87432; BAA13376.2; ALT_INIT; mRNA.
DR   EMBL; CR749291; CAH18146.1; -; mRNA.
DR   EMBL; CH471092; EAW83219.1; -; Genomic_DNA.
DR   EMBL; BC028216; AAH28216.1; -; mRNA.
DR   CCDS; CCDS32470.1; -.
DR   RefSeq; NP_001070253.1; NM_001076785.2.
DR   RefSeq; NP_003974.3; NM_003983.5.
DR   RefSeq; XP_011521735.1; XM_011523433.1.
DR   RefSeq; XP_011521736.1; XM_011523434.1.
DR   RefSeq; XP_011521740.1; XM_011523438.1.
DR   UniGene; Hs.679580; -.
DR   ProteinModelPortal; Q92536; -.
DR   BioGrid; 114519; 1.
DR   IntAct; Q92536; 2.
DR   STRING; 9606.ENSP00000219343; -.
DR   TCDB; 2.A.3.8.23; the amino acid-polyamine-organocation (apc) family.
DR   iPTMnet; Q92536; -.
DR   PhosphoSitePlus; Q92536; -.
DR   BioMuta; SLC7A6; -.
DR   DMDM; 190462822; -.
DR   EPD; Q92536; -.
DR   MaxQB; Q92536; -.
DR   PaxDb; Q92536; -.
DR   PeptideAtlas; Q92536; -.
DR   PRIDE; Q92536; -.
DR   DNASU; 9057; -.
DR   Ensembl; ENST00000219343; ENSP00000219343; ENSG00000103064.
DR   Ensembl; ENST00000566454; ENSP00000455064; ENSG00000103064.
DR   GeneID; 9057; -.
DR   KEGG; hsa:9057; -.
DR   UCSC; uc002evt.3; human.
DR   CTD; 9057; -.
DR   DisGeNET; 9057; -.
DR   GeneCards; SLC7A6; -.
DR   H-InvDB; HIX0013172; -.
DR   HGNC; HGNC:11064; SLC7A6.
DR   HPA; HPA050713; -.
DR   MIM; 605641; gene.
DR   neXtProt; NX_Q92536; -.
DR   OpenTargets; ENSG00000103064; -.
DR   PharmGKB; PA35924; -.
DR   eggNOG; KOG1287; Eukaryota.
DR   eggNOG; COG0531; LUCA.
DR   GeneTree; ENSGT00760000119037; -.
DR   HOGENOM; HOG000098892; -.
DR   HOVERGEN; HBG000476; -.
DR   InParanoid; Q92536; -.
DR   KO; K13872; -.
DR   OMA; GSSWDVG; -.
DR   OrthoDB; EOG091G07EM; -.
DR   PhylomeDB; Q92536; -.
DR   TreeFam; TF313355; -.
DR   BioCyc; MetaCyc:ENSG00000103064-MONOMER; -.
DR   Reactome; R-HSA-210991; Basigin interactions.
DR   Reactome; R-HSA-352230; Amino acid transport across the plasma membrane.
DR   SABIO-RK; Q92536; -.
DR   ChiTaRS; SLC7A6; human.
DR   GeneWiki; SLC7A6; -.
DR   GenomeRNAi; 9057; -.
DR   PRO; PR:Q92536; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000103064; -.
DR   CleanEx; HS_SLC7A6; -.
DR   ExpressionAtlas; Q92536; baseline and differential.
DR   Genevisible; Q92536; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0015171; F:amino acid transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0015297; F:antiporter activity; IBA:GO_Central.
DR   GO; GO:0015179; F:L-amino acid transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0006865; P:amino acid transport; TAS:Reactome.
DR   GO; GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0006461; P:protein complex assembly; TAS:ProtInc.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR002293; AA/rel_permease1.
DR   Pfam; PF13520; AA_permease_2; 1.
DR   PIRSF; PIRSF006060; AA_transporter; 1.
PE   1: Evidence at protein level;
KW   Amino-acid transport; Antiport; Cell membrane; Complete proteome;
KW   Disulfide bond; Membrane; Phosphoprotein; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    515       Y+L amino acid transporter 2.
FT                                /FTId=PRO_0000341477.
FT   TOPO_DOM      1     44       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     45     65       Helical. {ECO:0000255}.
FT   TOPO_DOM     66     78       Extracellular. {ECO:0000255}.
FT   TRANSMEM     79     99       Helical. {ECO:0000255}.
FT   TOPO_DOM    100    114       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    115    135       Helical. {ECO:0000255}.
FT   TOPO_DOM    136    167       Extracellular. {ECO:0000255}.
FT   TRANSMEM    168    188       Helical. {ECO:0000255}.
FT   TOPO_DOM    189    194       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    195    215       Helical. {ECO:0000255}.
FT   TOPO_DOM    216    235       Extracellular. {ECO:0000255}.
FT   TRANSMEM    236    256       Helical. {ECO:0000255}.
FT   TOPO_DOM    257    266       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    267    287       Helical. {ECO:0000255}.
FT   TOPO_DOM    288    311       Extracellular. {ECO:0000255}.
FT   TRANSMEM    312    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    363       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    364    384       Helical. {ECO:0000255}.
FT   TOPO_DOM    385    385       Extracellular. {ECO:0000255}.
FT   TRANSMEM    386    406       Helical. {ECO:0000255}.
FT   TOPO_DOM    407    425       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    426    446       Helical. {ECO:0000255}.
FT   TOPO_DOM    447    451       Extracellular. {ECO:0000255}.
FT   TRANSMEM    452    472       Helical. {ECO:0000255}.
FT   TOPO_DOM    473    515       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES      30     30       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BGK6}.
FT   CONFLICT      8      8       R -> G (in Ref. 3; CAH18146).
FT                                {ECO:0000305}.
FT   CONFLICT    388    388       Q -> R (in Ref. 3; CAH18146).
FT                                {ECO:0000305}.
SQ   SEQUENCE   515 AA;  56828 MW;  4E92F6E1972351A9 CRC64;
     MEAREPGRPT PTYHLVPNTS QSQVEEDVSS PPQRSSETMQ LKKEISLLNG VSLVVGNMIG
     SGIFVSPKGV LVHTASYGMS LIVWAIGGLF SVVGALCYAE LGTTITKSGA SYAYILEAFG
     GFIAFIRLWV SLLVVEPTGQ AIIAITFANY IIQPSFPSCD PPYLACRLLA AACICLLTFV
     NCAYVKWGTR VQDTFTYAKV VALIAIIVMG LVKLCQGHSE HFQDAFEGSS WDMGNLSLAL
     YSALFSYSGW DTLNFVTEEI KNPERNLPLA IGISMPIVTL IYILTNVAYY TVLNISDVLS
     SDAVAVTFAD QTFGMFSWTI PIAVALSCFG GLNASIFASS RLFFVGSREG HLPDLLSMIH
     IERFTPIPAL LFNCTMALIY LIVEDVFQLI NYFSFSYWFF VGLSVVGQLY LRWKEPKRPR
     PLKLSVFFPI VFCICSVFLV IVPLFTDTIN SLIGIGIALS GVPFYFMGVY LPESRRPLFI
     RNVLAAITRG TQQLCFCVLT ELDVAEEKKD ERKTD
//
